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Alcohol withdrawal syndrome is a potentially life-threatening condition, which can occur
when patients with alcohol use disorders undergo general anesthesia. Excitatory amino
acids, such as glutamate, act as neurotransmitters and are known to play a key role in alco-
hol withdrawal syndrome. To understand this process better, we investigated the influence
of isoflurane, sevoflurane, and desflurane anesthesia on the profile of excitatory and inhibi-
tory amino acids in the nucleus accumbens (NAcc) of alcohol-withdrawn rats (AWR).
Methods
Eighty Wistar rats were randomized into two groups of 40, pair-fed with alcoholic or non-
alcoholic nutrition. Nutrition was withdrawn and microdialysis was performed to measure the
activity of amino acids in the NAcc. The onset time of the withdrawal syndrome was first
determined in an experiment with 20 rats. Sixty rats then received isoflurane, sevoflurane,
or desflurane anesthesia for three hours during the withdrawal period, followed by one hour
of elimination. Amino acid concentrations were measured using chromatography and results
were compared to baseline levels measured prior to induction of anesthesia.
Results
Glutamate release increased in the alcohol group at five hours after the last alcohol intake
(p = 0.002). After 140 min, desflurane anesthesia led to a lower release of glutamate (p <
0.001) and aspartate (p = 0.0007) in AWR compared to controls. GABA release under and
after desflurane anesthesia was also significantly lower in AWR than controls (p = 0.023).
Over the course of isoflurane anesthesia, arginine release decreased in AWR compared to
controls (p < 0.001), and aspartate release increased after induction relative to controls
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(p20min = 0.015 and p40min = 0.006). However, amino acid levels did not differ between the
groups as a result of sevoflurane anesthesia.
Conclusions
Each of three volatile anesthetics we studied showed different effects on excitatory and
inhibitory amino acid concentrations. Under desflurane anesthesia, both glutamate and
aspartate showed a tendency to be lower in AWR than controls over the whole timecourse.
The inhibitory amino acid arginine increased in AWR compared to controls, whereas GABA
levels decreased. However, there were no significant differences in amino acid concentra-
tions under or after sevoflurane anesthesia. Under isoflurane, aspartate release increased
in AWR following induction, and from 40 min to 140 min arginine release in controls was ele-
vated. The precise mechanisms through which each of the volatile anesthetics affected
amino acid concentrations are still unclear and further experimental research is required to
draw reliable conclusions.
Introduction
Alcohol use disorder is one of the most common causes of critical illness [1], with a lifetime
prevalence of alcohol abuse in US adults of around 18% [2]. A quarter of patients with long
term alcohol abuse will develop alcohol withdrawal syndrome (AWS) [3]. AWS is responsible
for many comorbidities, including chronic disorders [4], and can lead to delirium tremens, a
potentially life-threatening condition [5]. Alcohol interacts with a variety of protein targets in
the central nervous system, including the glutamatergic, noradrenergic, dopaminergic, seroto-
nergic, GABAergic and cholingergic receptor systems [6,7].
The nucleus accumbens (NAcc) is critical to the neocortical modulation of neurotransmit-
ters. It plays a central role of the cortico-striato-thalamic-cortical-loop, using both excitatory
and inhibitory transmitters to regulate signal transduction. Under physiological conditions,
these excitatory and inhibitory systems are in balance. However, chronic alcohol consumption
lowers glutamate levels in several regions of the brain including the striatum [7], which is
important in mediating the alcohol withdrawal response [8]. Chronic alcohol intake also
increases N-Methyl-D-aspartate (NMDA) receptor expression [9], and increased glutamate
release following alcohol withdrawal results in an excessive excitatory activation via upregu-
lated NMDA receptors. These changes are postulated to be responsible for causing the typical
AWS symptoms, such as seizures and hyperexcitability [10].
When patients with alcohol use disorder have to undergo general anesthesia, alcohol with-
drawal is often inevitable. Reports suggest that every fourth patient admitted to a surgical ward
is positive for alcoholism [11], and that over the course of a stay at a postoperative intensive
care unit, up to 35% of all patients show AWS [12].
General anesthetic agents elevate the activity of inhibitory neurotransmitter systems and
decrease excitatory transmitter levels. However, it is unknown at present whether volatile anes-
thetics attenuate the increased excitatory amino acid levels seen in AWS.
Therefore, the aim of this pilot study was to investigate the influence of isoflurane, sevoflur-
ane, and desflurane anesthesia on important excitatory and inhibitory amino acids in the
NAcc of alcohol-withdrawn rats (AWR), which are an animal model of AWS.
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Eighty male rats (Wistar Unilever Outbred Rat; Stocks: HsdCpb:WU; Harlan Winkelmann,
Borchen, Germany) were used according to experimental protocol G 0299/08. All procedures
were approved by the institutional animal care board of the Landesamt fu¨r Gesundheit und
Soziales (LAGeSo) in Berlin, Germany. The rats were housed in single cages under standard
conditions (22 ± 1˚C, day phase from 6 am to 6 pm), and habituated to manual handling for
one week before the alcohol uptake period started. A two-bottle choice method, which is well
established and frequently used by other study groups [13], was used to induce voluntary alco-
hol dependence in the rats. We modified the method to permit continuous rather than inter-
mittent access, as other studies have done [14]. This allowed the first withdrawal response to
occur during the experimental trial. The animals were randomized into two groups of 40,
which were fed with either an alcoholic liquid nutrition (alcohol or treatment group) or a non-
alcoholic liquid nutrition (control group) [15]. Apart from their different liquid diets, both
groups received the same treatment throughout the experiment. Ethanol was added to the liq-
uid diet to obtain a 5% concentration (v/v). In the non-alcoholic nutrition, isocaloric malto-
dextrin was added in place of ethanol, at the same concentration. Water was provided ad
libitum, and liquid nutrition was pair-fed to the rats for 26 days (Fig 1) to give long enough for
a sufficient withdrawal response to develop [16]. Prior studies with oral alcohol feeding proto-
cols have shown that concentrations of 100–200 mg/dl are sufficient to induce alcohol addic-
tion in rats [13,17,18]. After the 26 days, liquid food was withheld from both groups, in order
to induce an alcohol withdrawal response in the alcohol group. Microdialysis trials were per-
formed to measure the levels of amino acid neurotransmitters in the NAcc during the with-
drawal response.
In vivo microdialysis in freely moving rats
Microdialysis trials were performed as previously described [19]. On the 23rd day of the feed-
ing protocol (Fig 1), microdialysis cannulae were implanted in the NAcc according to the atlas
of Paxinos and Watson using a stereotactic apparatus [20]. Each animal was anesthetized via
intramuscular anesthesia using 120 mg/kg ketamine (Ketavet1, 100 mg/mL, Pfizer, New York,
New York) and 5 mg/kg xylazine (Rompun1 2%, Bayer, Leverkusen, Germany). The anesthe-
tized rat was placed on the stereotactic apparatus to allow implantation of a microdialysis can-
nula above the right NAcc core region according to the following coordinates: anterior 0.12
Fig 1. Schedule for the feeding period.
doi:10.1371/journal.pone.0169017.g001
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cm, lateral 0.14 cm, and ventral -0.55 cm, relative to bregma and the dura. The cannula was
anchored to the skull using two screws and dental cement.
Rats were allowed to recover in their cages for the following three days, and continued the
feeding protocol (Fig 1).
After the last feeding on day 26, a microdialysis probe (MAB 4.15.2. Cut off: 6 kDa; 4
Cuprophane; 3 mm dialysis membrane) was placed into the right core region of the NAcc and
perfused with artifical cerebrospinal fluid (aCSF: 145 mM NaCl; 1.25 mM CaCl2; 2.8 mM KCl;
1.2 mM MgCl26H2O; 1.25 mM NaH2PO4H2O; pH 7.3; 2 μl/min). During the collection
period, a balanced arm with a dual channel swivel was connected to the perfusion line and
samples were gathered by an automated sample collector (CMA 140), which was maintained
at 6˚C. After collection, the perfusate was frozen at -80˚C until further analysis. Cannulas,
probes, and microdialysis equipment were provided by CMA (Solna, Sweden).
Determination of the withdrawal onset time
In order to determine the time of onset of AWS, 10 rats randomly chosen from each of the
alcohol and control groups were analyzed. The microdialysis probe was placed as described
above, and microdialysate samples were collected at 60 minute intervals for 24 hours (Fig 2).
The data collected during the first three hours were used to calculate baseline levels of the
amino acids, and then nutrition was withheld. In line with recent studies [19,21], we defined
the time at which we first observed a significant difference in glutamate levels between the
alcohol and control groups as the “onset time of the withdrawal response”.
Inhalational anesthesia during withdrawal
Thirty rats from each of the alcohol and control groups were used to study the effects of inhala-
tional anesthesia on amino acid levels in the NAcc. Nutrition was withheld and microdialysis
probes were inserted into position (Fig 3). After three hours of recovery microdialysate sam-
ples were collected. The first two hours of microdialysis measurements were used to generate
the baseline. Experimental microdialysate samples were collected after this baseline period at
20 min intervals over a total period of 360 min. Anesthesia was induced in both groups five
hours after food was withheld (matching the time point labeled “0” in Fig 3) in order to achieve
a maximal withdrawal response, according to our findings from the experiment above. The
thirty rats from each group were divided into three sub-groups which underwent inhalational
anesthesia, receiving isoflurane, sevoflurane, or desflurane for 180 min, respectively, at a mini-
mal alveolar concentration of 1. Body temperature was controlled using a heating pad and
held at 37 ± 0.5˚C, so as to prevent hypothermia.
Fig 2. Experimental schedule for determining the withdrawal onset time.
doi:10.1371/journal.pone.0169017.g002
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Microdialysis was performed until one hour after emergence of anesthesia, in order to eval-
uate the elimination period of the anesthesia. After collection, perfusate was immediately fro-
zen at -80˚C until further analysis.
Verification of probe position
Each animal was euthanized, then decapitated with a guillotine. To verify proper probe place-
ment histologically, brains were first removed and preserved with 10% formalin in a 25%
sucrose solution. For slicing, preserved brains were frozen on ice and then 100 μm thick coro-
nal sections were cut with a vibratome and mounted on slides. Correct probe placement was
verified in brains using a light microscope, according to the rat brain atlas of Paxinos and Wat-
son [20].
Amino acid analysis
The glutamate concentrations of microdialysate samples were analyzed, with samples collected
during and after inhalational anesthesia being additionally analyzed for their aspartate, argi-
nine, and GABA concentrations. Analysis was performed via reverse-phase high performance
liquid chromatography (RP-HPLC; Bischoff Chromatography, Leonberg, Germany; and
Merck, Darmstadt, Germany), using a fluorescence detector with an excitation wavelength of
330 nm and an emission cut-off filter at 450 nm. The reverse-phase ion-pairing column was
prepacked with sulfonamidochrysoïdine (Prontosil) 120-3-C18 ace-EPS, 3 μm particulate sur-
face 300 m2/g (Bischoff Chromatography, Leonberg, Germany). The mobile phase A contained
50 mM sodium acetate at pH 6.2 with 5% acetonitrile, and the mobile phase B contained 75%
acetonitrile. The flow rate was 0.6 ml/min. The derivatization was performed automatically
with a sampler maintained at 4˚C (231 XL, Gilson, Middleton, Wisconsin). To identify the
amino acids (glutamate, aspartate, arginine, and GABA), peaks were equalized to the standard
peaks of these substrates. The detection limit of all amino acids was 0.05 pmol. Quantification
was performed by integrating the area under the curve (AUC).
Statistical analysis
The study in its entirety was planned and performed as an observational pilot study, meaning
that the sample size was not statistically estimated beforehand.
Results are given as the mean with standard deviation [SD], or the median with 25% to 75%
quartiles, in cases where the data deviated from a normal distribution. Due to the small sample
sizes, only non-parametric tests were performed.
Fig 3. Experimental schedule for induction and microdialysis measurement of volatile anesthesia.
doi:10.1371/journal.pone.0169017.g003
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The absolute quantified amino acid concentrations from the AUC of the RP-HPLC analyses
were expressed as percentages relative to the mean basal values, which were calculated as the
mean of the three samples prior to the intervention. Microdialysis samples were collected at 60
minute intervals. The withdrawal onset time was defined as the earliest timepoint at which
there was a significant difference between the alcohol and control groups, according to non-
parametric Mann-Whitney U tests calculated at each timepoint.
In order to analyze inhalational anesthesia during withdrawal, microdialysis samples were
collected at 20 min intervals for a total of 6 hours. The baseline was defined as the mean of
the first six samples prior to anesthesia. Longitudinal data were analyzed using a two-way
nonparametric repeated-measures MANOVA factorial design (1st, independent factor
[treat]: alcohol and control groups; 2nd, dependent factor [time]: repetitions across time).
This allowed us to analyze group differences between alcohol and control groups over time,
including tests for differences between treatments [treat], systematic changes in time [time],
and interactions between treatments and time [treattime]. Post-hoc analyses were per-
formed using Mann-Whitney U tests, in order to determine the timepoints at which signifi-
cant differences occurred.
The data in the figures are expressed as percent of baseline, median with 25% to 75% per-
centiles, and time elapsed. All tests were performed as exploratory data analyses, and as such
no adjustments for multiple testing have been made. The level of significance for these explor-
atory analyses was set at p< 0.05, p< 0.01 and p< 0.001. Numerical calculations were
performed with IBM SPSS Statistics for Windows (Version 21.0; IBM Corp., Armonk, New
York), and SAS 9.1 (SAS Institute, Inc., Cary, North Carolina).
Results
Exclusion rate
In order to determine the onset time of alcohol withdrawal, we randomly selected 20 rats (10
from the alcohol group and 10 controls). Due to technical difficulties and dislocation of micro-
dialysis probes, only 14 rats could be included (8 rats in the control group and 6 in the alcohol
group).
A total of 60 rats received inhalational anesthesia during withdrawal. Two animals died of
unknown causes during recovery following implantation of the microdialysis cannula. Both
rats belonged to the alcohol group, and had been previously assigned to the isoflurane and
sevoflurane anesthesia sub-groups. Microdialysis data from two rats receiving desflurane, one
in the alcohol group and the other in the control group, could not be analyzed due to technical
difficulties, and therefore were excluded from further analyses.
In cases where a single microdialysis measurement was missing from an individual animal,
we have disregarded data from that timepoint in the affected animal only.
Animals and alcohol uptake
On the day of microdialysis, the average weight of the control rats was 296 g (SD = 15.6 g),
compared to 277 g (SD = 17.6 g) for the AWR (p < 0.001). Before the stereotactic operation
was performed, daily alcohol uptake was 2.21 g/day (SD = 0.46 g/day), which decreased to 1.70
g/day (SD = 0.5 g/day) between the operation and the beginning of microdialysis.
Determination of the withdrawal onset time
Data collected from the alcohol and control group rats were compared at each timepoint (Fig
4). The baseline glutamate concentration was calculated as the mean of the values during the
Influence of Volatile Anesthesia on Amino Acids in Alcohol-Withdrawn Rats
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two hours before nutrition was withheld. The withdrawal response, defined as the time of the
first significant difference in glutamate concentrations between the two groups, was detected
five hours after food was withheld (p5h = 0.002). Within the alcohol group, a few rats showed
an earlier increase in glutamate release, resulting in a large interquartile range from the 2nd
hour onwards.
Inhalational anesthesia during withdrawal
Each of the three volatile anesthetics (isoflurane, sevoflurane and desflurane) was administered
to three sub-groups of rats from the alcohol and control groups. We did not perform any sta-
tistical comparisons of the relative effects of the different anesthetics. The baseline was calcu-
lated as the mean of the samples in the two hours prior to the onset of anesthesia. In the
microdialysis plots in Figs 4–8, the starting value at 0 min is 100% for all groups (not plotted).
Glutamate level
MANOVA factorial analyses revealed significant differences in glutamate concentration over
time during isoflurane (p = 0.035), sevoflurane (p = 0.009), and desflurane (p< 0.001) anes-
thesia (Table 1). However at any of the individual timepoints during isoflurane and sevoflur-
ane anesthesia, glutamate release in AWR and controls did not differ significantly (Fig 5).
Under desflurane, glutamate concentration was elevated in AWR compared to controls at
the first timepoint (20 min; p20min = 0.049), but was lower for every timepoint after 140 min,
except at 200 min (p140min = 0.014, p160min = 0.007, p180min = 0.019, p220min = p240min = 0.007).
A similar pattern was observed under isoflurane, as glutamate concentration was lower in
AWR relative to controls at the final timepoint (p240min = 0.023).
Fig 4. Elevated glutamate levels in the alcohol group compared to controls indicate that the alcohol
withdrawal response occurred five hours after the last intake of alcohol. Glutamate release as median
% of baseline with interquartile ranges (25–75%) plotted over time (control: n = 8; alcohol: n = 6). Group
statistical analyses were performed using Mann-Whitney U tests (**p < 0.01).
doi:10.1371/journal.pone.0169017.g004
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Aspartate level
MANOVA factorial analyses showed that sevoflurane anesthesia caused systematic changes in
aspartate concentration over time (p< 0.001) (Table 2). Under desflurane the MANOVA anal-
ysis revealed differences between alcohol and control groups (p = 0.004), with post-hoc tests
showing significantly lower aspartate in AWR compared to controls at later timepoints (p140min
= 0.014, p160min = p220min = p240min = 0.007, p180min = 0.019). After induction of isoflurane anes-
thesia (Fig 6), aspartate release in AWR was increased at first compared to controls (p20min =
0.015 and p40min = 0.006), and subsequently dropped back to baseline levels. At one timepoint,
the aspartate concentration in AWR fell below that of the control group (p140min = 0.027).
Fig 5. Glutamate release under desflurane was lower in AWR compared to controls for all timepoints from 140 mins onwards,
except at 200 min. Glutamate release in the alcohol vs. control groups during withdrawal under volatile anesthesia (0–180 min), emergence
(#) and post-anesthesia recovery (200–240 min). Data are shown as median % of baseline with interquartile ranges (25–75%) and plotted
over time. (A) isoflurane: alcohol vs. control, n = 9 vs. 10. (B) sevoflurane: alcohol vs. control, n = 9 vs. 10. (C) desflurane: alcohol vs. control,
n = 9 vs. 9. Post-hoc univariate group comparisons were performed using Mann-Whitney U tests. (*p < 0.05 and **p < 0.01).
doi:10.1371/journal.pone.0169017.g005
Fig 6. Aspartate levels under the different volatile anesthetics. Aspartate release in the alcohol vs. control groups during withdrawal
under volatile anesthesia (0–180 min), emergence (#) and post-anesthesia recovery (200–240 min). Data are shown as median % of
baseline with interquartile ranges (25–75%) and plotted over time. (A) isoflurane: alcohol vs. control, n = 9 vs. 10. (B) sevoflurane: alcohol vs.
control, n = 9 vs. 10. (C) desflurane: alcohol vs. control, n = 9 vs. 9. Post-hoc univariate group comparisons were performed using Mann-
Whitney U tests (*p < 0.05 and **p < 0.01).
doi:10.1371/journal.pone.0169017.g006
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Arginine level
Under all three of the volatile anesthetics, the release of arginine (Fig 7) showed significant sys-
tematic changes in time (p< 0.001) according to MANOVA analyses (Table 3). These analyses
revealed significant differences between the alcohol and control groups under isoflurane
(p = 0.002) and desflurane (p = 0.01).
Post-hoc analyses showed that during isoflurane anesthesia, arginine release in AWR was
lower than the control group at the majority of the timepoints measured (p40min = 0.035,
p60min = 0.036, p100min = 0.027, p120min < 0.001, p140min < 0.001). In contrast, desflurane led to
an elevated release of arginine in AWR compared to controls at several timepoints (p100min =
0.014, p180min = 0.003, p200min = 0.008, p220min = 0.012, p240min = 0.009).
Fig 7. Arginine levels under the different volatile anesthetics. Arginine release in the alcohol vs. control groups during withdrawal under
volatile anesthesia (0–180 min), emergence (#) and post-anesthesia recovery (200–240 min). Data are shown as median % of baseline with
interquartile ranges (25–75%) and plotted over time. (A) isoflurane: alcohol vs. control, n = 9 vs. 10. (B) sevoflurane: alcohol vs. control, n = 9
vs. 10. (C) desflurane: alcohol vs. control, n = 9 vs. 9. Post-hoc univariate group comparisons were performed using Mann-Whitney U tests.
(*p < 0.05, **p < 0.01 and ***p < 0.001).
doi:10.1371/journal.pone.0169017.g007
Fig 8. The GABA concentration was lower in AWR than controls under desflurane anesthesia. GABA release in the alcohol vs.
control groups during withdrawal under volatile anesthesia (0–180 min), emergence (#) and post-anesthesia recovery (200–240 min). Data
are shown as median % of baseline with interquartile ranges (25–75%) and plotted over time (A) isoflurane: alcohol vs. control, n = 9 vs. 10.
(B) sevoflurane: alcohol vs. control, n = 9 vs. 10. (C) desflurane: alcohol vs. control, n = 9 vs. 9. Post-hoc univariate group comparisons were
performed using Mann-Whitney U tests (*p < 0.05 and **p < 0.01).
doi:10.1371/journal.pone.0169017.g008
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GABA level
MANOVA analyses showed that isoflurane caused systematic changes in GABA concentra-
tions over time (p = 0.002) (Table 4). The MANOVA revealed significant differences between
the alcohol and control groups under desflurane (p = 0.023), with post-hoc analyses on indi-
vidual timepoints (Fig 8) showing that GABA release was lower in AWR than controls both
Table 1. P-values for differences in glutamate concentration from MANOVA analyses.
Hypotheses Isoflurane: alcohol vs. control (p-values) Sevoflurane: alcohol vs. control (p-values) Desflurane alcohol vs. control (p-values)
[treat] .42297 .30625 .08708
[time] .03486 .00941 < 0.001
[treat*time] .04791 .41992 < 0.001
Multivariate nonparametric analyses of longitudinal data were performed using a two-way factorial design (1st, independent factor [treat]: alcohol and control
groups; 2nd, dependent factor [time]: repetitions in time; nonparametric MANOVA for repeated measures). P-values were calculated for comparison of
treatment groups (alcohol vs. control) [treat], systematic changes in time [time], and interactions between treatment group and time [treat*time].
doi:10.1371/journal.pone.0169017.t001
Table 2. P-values for differences in aspartate concentration from MANOVA analyses.
p-values Isoflurane: alcohol vs. control (p-values) Sevoflurane: alcohol vs. control (p-values) Desflurane: alcohol vs. control (p-values)
[treat] .70391 .73800 .00401
[time] .12853 .00025 .00071
[treat*time] .01511 .43720 .00293
Multivariate nonparametric analyses of longitudinal data were performed using a two-way factorial design (1st, independent factor [treat]: alcohol and control
groups; 2nd, dependent factor [time]: repetitions in time; nonparametric MANOVA for repeated measures). P-values show significance for group (alcohol vs.
control) differences between treatment [treat], systematic changes in time [time], and interactions between treatment group and time [treat*time].
doi:10.1371/journal.pone.0169017.t002
Table 3. P-values for differences in arginine concentration from MANOVA analyses.
p-values Isoflurane: alcohol vs. control (p-values) Sevoflurane: alcohol vs. control (p-values) Desflurane: alcohol vs. control (p-values)
[treat] .00243 .56548 .00984
[time] < 0.001 < 0.001 < 0.001
[treat*time] .22394 .73548 .17936
Multivariate nonparametric analyses of longitudinal data were performed using a two-way factorial design (1st, independent factor [treat]: alcohol and control
groups; 2nd, dependent factor [time]: repetitions in time; nonparametric MANOVA for repeated measures). P-values show significance for group (alcohol vs.
control) differences between treatment [treat], systematic changes in time [time], and interactions between treatment group and time [treat*time].
doi:10.1371/journal.pone.0169017.t003
Table 4. P-values for differences in GABA concentration from MANOVA analyses.
p-values Isoflurane: alcohol vs. control (p-values) Sevoflurane: alcohol vs. control (p-values) Desflurane: alcohol vs. control (p-values)
[treat] .11200 .79603 .02314
[time] .00222 .22409 .06374
[treat*time] .05414 .60808 .77384
Multivariate nonparametric analyses of longitudinal data were performed using a two-way factorial design (1st, independent factor [treat]: alcohol and control
groups; 2nd, dependent factor [time]: repetitions in time; nonparametric MANOVA for repeated measures). P-values show significance for group (alcohol vs.
control) differences between treatment [treat], systematic changes in time [time], and interactions between treatment group and time [treat*time].
doi:10.1371/journal.pone.0169017.t004
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during and after desflurane anesthesia (p40min = p60min = 0.019, p80min = 0.015, p120min = 0.026,
p140min = p200min = 0.009, p220 min = 0.041).
Discussion
Our findings showed that glutamate concentrations increase after alcohol withdrawal in rats
with chronic alcohol uptake (Fig 4), in agreement with many published studies [19,21–23].
The onset time of the alcohol withdrawal response was defined as the earliest timepoint at
which we measured a significant difference in glutamate levels between the alcohol and control
groups in the core region of the NAcc. This method has been used previously in similar experi-
mental designs [19]. Although interindividual variability was broad, this response was found
to take place around five hours after the last oral alcohol uptake, which is consistent with find-
ings from other research groups [19,24].
To synchronize with this withdrawal response, in the second trial volatile anesthesia was
induced five hours after the last oral alcohol uptake, when a significant release of glutamate
was expected. During anesthesia, there were no significant differences in glutamate concentra-
tion between the alcohol and control groups under isoflurane or sevoflurane, although there
was a large variability in the first timepoint measured in AWR under isoflurane. A modest
increase in glutamate release in AWR was seen immediately after induction with desflurane.
However at later timepoints, glutamate release in AWR decreased below that in controls.
Analogous to glutamate release, aspartate release of AWR in the desflurane sub-group
showed a tendency to be lower over the entire timecourse of microdialysis, with significant dif-
ferences apparent from 140 min after induction. Under sevoflurane anesthesia, there were no
apparent group differences in aspartate release. Induction of isoflurane caused an increase in
aspartate release in AWR relative to controls for the first 40 minutes of anesthesia.
Aspartate is an excitatory neurotransmitter of the NMDA receptor [25], but the excitotoxi-
city seems to be less severe in comparison to glutamate [26]. Both glutamate and aspartate, the
excitatory amino acids we measured in this study, are absorbed out of the synaptic gap mostly
due to excitatory amino acid transporters (EAAT). These transporters are the most important
regulators of excitatory neurotransmission [27], but their function is reduced under chronic
alcohol exposure [28], leading to impaired glutamate uptake during withdrawal.
The different EAAT are thought to be partly responsible for the varying effects of each of
the volatile anesthetics, but the precise molecular pathways underlying these effects remain
unclear. Volatile anesthetics reduce exocytosis [29,30], and increase excitatory transmitter
uptake [31,32]. An increased activity of EAAT3 has been shown under isoflurane, sevoflurane,
and desflurane anesthesia [30,33–36], and is mediated by activated proteinkinase C (PKC)
[35]. PKC plays a central regulatory role via potentiation of NMDA receptor trafficking [37].
It is remarkable that neuronal structures adapted to alcohol seem to respond more sensi-
tively to volatile anesthesia, and are more efficient in reducing excitatory neurotransmitters
than those that are not adapted.
Under each volatile anesthetic, our data showed an increase in arginine release over the
entire microdialysis timecourse, both in AWR and alcohol-naïve rats. When compared to the
control group, the release of arginine in the AWR group was lower under isoflurane, equal
under sevoflurane, and higher under desflurane. GABA release under isoflurane increased
over the timecourse, according to the known mode of action. However under sevoflurane, we
did not measure any increase in GABA release. Under desflurane, GABA release was lower in
AWR than controls at the majority of the timepoints measured. These results might be due to
limitations in the microdialysis approach, since the potentiation of GABA-induced currents
[38] cannot be measured by this method.
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Limitations to the Study
Since this study was performed as a pilot study, we did not statistically estimate the sample size
beforehand. A possible consequence of this is that the data sample collected was not suffi-
ciently large to show significant differences for particular comparisons.
The spread of data in the alcohol group may reflect variability due to differences in individ-
ual metabolism and alcohol uptake behavior from the unforced uptake protocol, which we
used based on the recommendations of the institutional animal care board. Comparable stud-
ies with strict, regular feeding procedures, such as intragastric feeding or intraperitoneal appli-
cation, showed lower variability but a similar onset time for withdrawal.
In this study, every anesthetic treatment group was matched with its own control group.
This method is not suitable for comparing the treatment groups, and so direct comparisons of
the three anesthetics to each other cannot be made.
Although sevoflurane and desflurane are routinely used in clinical practice, only a few
experimental studies have been published which investigate the mode of action and effects of
both anesthetics. Isoflurane is predominantly used in such experiments, although it is rarely
used in clinical practice in industrialized nations. This fact makes a reliable translation of our
results to human clinical practice difficult.
Volatile anesthetics have an alcohol-like effect on the NMDA receptor through their action
as noncompetitive antagonists [39], and isoflurane even leads to a compensatory increase in
expression of the NMDA subunit NR2B [40]. To evaluate the total inhibitory effect of the anes-
thetics, it is necessary to consider not only the concentration of transmitters, but also their
induced currents and postsynaptic effects. The microdialysis approach alone is not sufficient
to measure such effects.
Conclusion
In this study, we showed an increased glutamate release in AWR during alcohol withdrawal
compared to controls. Desflurane induction led to a moderate glutamate increase in AWR,
whereas aspartate and GABA levels gradually decreased over the timecourse, following the
increase in glutamate release. Under isoflurane, aspartate release was elevated in AWR com-
pared to controls after induction, whilst the controls showed higher arginine concentrations.
There were no group differences under sevoflurane anesthesia. All three anesthetics intensified
the release of arginine over the timecourse.
Due to the complexity and lack of clarity regarding the mechanisms of action of the anes-
thetics, presenting reliable explanations for the effects we observed would be challenging.
Since EAAT are the most important known regulators of excitatory neurotransmission, their
differing affinities with each of the volatile anesthetics used in this study may explain their vari-
able effects, and could be a good starting point for further research.
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